PHARMACYCLICS INC
PCYC
PCYC was delisted on the 22nd of May, 2015.
224 hedge funds and large institutions have $6.59B invested in PHARMACYCLICS INC in 2013 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 67 increasing their positions, 87 reducing their positions, and 30 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 4 → 8 (+4)
83% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 30
70% more capital invested
Capital invested by funds: $3.88B → $6.59B (+$2.72B)
11% more funds holding
Funds holding: 201 → 224 (+23)
23% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 87
35% less call options, than puts
Call options by funds: $138M | Put options by funds: $211M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$179M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$112M |
| 3 |
FAM
Fred Alger Management
New York
|
+$48M |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$44.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$38.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$195M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$48.3M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$39.2M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$37.4M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$35.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QI
251
Quotient Investors
New York
| – | -$230K | -2,900 | Closed |
|
|
T
252
TradeWorx
Red Bank,
New Jersey
| – | -$209K | -2,625 | Closed |
|
|
OMCS
253
Old Mutual Customised Solutions
Pinelands,
South Africa
| – | -$48K | -600 | Closed |
|
254
Bessemer Group
Woodbridge,
New Jersey
| – | -$1K | -8 | Closed |
|
PCYC Hedge Fund Activity: Q3 2013 in Review
224 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q3 2013, worth a combined $6.59B — up 70% from $3.88B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new PCYC positions and 30 closed out — a net gain of 25 holders — while 67 added to existing stakes and 87 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was Baker Bros. Advisors, cutting an estimated $195M.
- 224 institutional investors held PHARMACYCLICS INC (PCYC) as of Q3 2013, up from 201 in Q2 2013.
- Funds reported $6.59B of PHARMACYCLICS INC stock for Q3 2013, up 70% quarter-over-quarter.
- 55 funds opened new PHARMACYCLICS INC positions in Q3 2013 and 30 closed out, a net change of +25 holders.
- The largest PHARMACYCLICS INC buyer in Q3 2013 was Fidelity Investments, an estimated $179M added.
- The largest PHARMACYCLICS INC seller in Q3 2013 was Baker Bros. Advisors, an estimated $195M sold.
Based on aggregated 13F filings for Q3 2013.